Cytotoxic Chemotherapy and Endocrine Therapy for Hepatocellular Carcinoma
作者： Daniel Palmer , Philip J. Johnson
DOI: 10.1007/978-1-60327-522-4_21
关键词:
摘要: For the minority of patients with hepatocellular carcinoma (HCC), surgical therapy, including transplantation, or local ablation may offer prospect cure (see Chapters 9–17). However, these treatments are typically constrained by size and/or number tumours as well liver dysfunction and other comorbidities.
springer.com
sci-hub.st 参考文章(81)
Yamanoi A, Ono T, Nagasue N, Uchida M, Kohno H, Hayashi T, Yukaya H, Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Seminars in Oncology. ,vol. 24, ,(1997)
Yasutoshi Muto, Hisataka Moriwaki, Mitsuo Ninomiya, Sadashi Adachi, Akiko Saito, Ken Takeshi Takasaki, Takuji Tanaka, Kaito Tsurumi, Masataka Okuno, Eiichi Tomita, Toshiyuki Nakamura, Takao Kojima, Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 334, pp. 1561- 1567 ,(1996) , 10.1056/NEJM199606133342402
Tadashi Horimi, Katsuyuki Kiura, Hiroaki Tanioka, Akihito Tsuji, Takaaki Mizushima, Koji Ochi, Sojiro Morita, Tetsuhiko Shirasaka, Masahiro Takamatsu, Mitsune Tanimoto, Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma. Anticancer Research. ,vol. 23, pp. 1891- 1897 ,(2003)
Melia Wm, Johnson Pj, Williams R, Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma. Cancer treatment reports. ,vol. 71, pp. 1213- 1216 ,(1987)
Ruey-Long Hong, Yun-Long Tseng, A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma Cancer Chemotherapy and Pharmacology. ,vol. 51, pp. 433- 438 ,(2003) , 10.1007/S00280-003-0583-2
C Grimaldi, H Bleiberg, F Gay, M Messner, P Rougier, T C Kok, L Cirera, A Cervantes, J De Greve, B Paillot, M Buset, D Nitti, T Sahmoud, N Duez, J Wils, Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial. Journal of Clinical Oncology. ,vol. 16, pp. 411- 417 ,(1998) , 10.1200/JCO.1998.16.2.411
U. Halm, G. Etzrodt, I. Schiefke, F. Schmidt, H. Witzigmann, J. Mössner, F. Berr, A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma Annals of Oncology. ,vol. 11, pp. 113- 114 ,(2000) , 10.1023/A:1008386822906
Tat Kuen Choi, Nim Wang Lee, John Wong, Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy Cancer. ,vol. 53, pp. 401- 405 ,(1984) , 10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L
Charles L. M. Olweny, Tom Toya, Edward Katongole-Mbidde, Josua Mugerwa, Sebastian K. Kyalwazi, Herman Cohen, Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication Cancer. ,vol. 36, pp. 1250- 1257 ,(1975) , 10.1002/1097-0142(197510)36:4<1250::AID-CNCR2820360410>3.0.CO;2-X
Ching‐Lung Lai, Anna Suk‐Fong Lok, Pui‐Chee Wu, Gerald Chee‐Bunn Chan, Hsiang‐Ju Lin, None, Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer. ,vol. 62, pp. 479- 483 ,(1988) , 10.1002/1097-0142(19880801)62:3<479::AID-CNCR2820620306>3.0.CO;2-L